不同程度冠状动脉狭窄患者应用64层螺旋CT诊断的临床分析

来源 :中国实用医药 | 被引量 : 0次 | 上传用户:borinz
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的分析不同程度冠状动脉狭窄患者应用64层螺旋CT诊断的临床价值。方法选取60例疑似冠心病患者作为研究对象,分别采用64层螺旋CT和常规冠状动脉造影进行诊断,观察64层螺旋CT诊断结果的正确率、特异性、敏感度、阳性预测值、阴性预测值。结果在轻度狭窄程度的诊断上,64层螺旋CT诊断漏诊4个;在中度狭窄程度的诊断上,64层螺旋CT诊断漏诊7个;在重度狭窄程度的诊断上,64层螺旋CT诊断多诊2个。64层螺旋CT在诊断轻度狭窄的敏感性为85.7%、特异性为96.7%、阳性预测值为89.1%、阴性预测值为94.8%;在诊断中度狭窄的敏感性为87.4%、特异性为97.8%、阳性预测值为91.8%、阴性预测值为97.8%;在诊断重度狭窄的敏感性为96.9%、特异性为99.0%、阳性预测值为94.1%、阴性预测值为96.9%。结论应用64层螺旋CT诊断不同程度冠状动脉狭窄患者,其诊断正确率、特异性、敏感度及阳性阴性预测值都非常高,具有重要的临床价值。 Objective To analyze the clinical value of 64-slice spiral CT in the diagnosis of patients with coronary artery stenosis. Methods Totally 60 patients with suspected coronary heart disease were selected as subjects for diagnosis by 64-slice spiral CT and routine coronary angiography. The diagnostic accuracy, specificity, sensitivity, positive predictive value and negative predictive value of 64-slice spiral CT were observed. . Results In the diagnosis of mild degree of stenosis, the 64-slice spiral CT diagnosis missed 4; in the diagnosis of moderate stenosis, the 64-slice spiral CT diagnosis missed 7; in the diagnosis of severe stenosis, 64-slice spiral CT diagnosis Multi-diagnosis 2. The sensitivity, specificity, and specificity of 64-slice spiral CT were 85.7%, 96.7%, 89.1%, and 94.8%, respectively. The sensitivity and specificity of 64-slice spiral CT were 87.4% and 87.4% The positive predictive value was 97.8%. The positive predictive value was 91.8%. The negative predictive value was 97.8%. The sensitivity and specificity of the diagnosis of severe stenosis were 96.9% and 99.0% respectively. The positive predictive value was 94.1% and negative predictive value was 96.9%. Conclusion The diagnostic accuracy, specificity, sensitivity and negative predictive value of 64-slice spiral CT in patients with different degrees of coronary artery stenosis are both very high and have important clinical value.
其他文献
期刊
期刊
期刊
期刊
期刊
期刊
期刊
期刊
经鼻高流量氧疗(HFNC)作为一种新兴无创呼吸支持技术,近年来在国内外广泛用于免疫抑制患者急性呼吸衰竭(ARF)的治疗。与传统氧疗(COT)、无创正压通气(NIV)等相比,HFNC可降低患者不适感,有效减少免疫抑制患者ARF的发展,尽管与COT相比未能降低此类患者的病死率,但可降低插管率,还可改善移植、实体癌等患者的预后。虽然HFNC治疗效果与病原学间的相关性尚未明确,但HFNC具有重要临床应用价
期刊